Venter Raises Stakes for “$1,000 Genome” Prize



Adding even greater incentive to scientists striving to realize the era of the $1,000 genome sequence, J. Craig Venter announced today that he is seeking to increase the size of his foundation’s prize from $500,000 to as much as $10 million.

Venter made his surprise announcement in his role as host of the Genomes, Medicine and the Environment conference, currently taking place in Hilton Head, SC. He spoke at the conclusion of a strong session featuring presentations from three companies rapidly commercializing new sequencing technologies – 454 Life Sciences, Solexa, and Helicos.

Those presentations clearly demonstrated dramatic progress in DNA sequencing technology. 454 published a landmark paper in Nature earlier this year demonstrating the sequencing of a bacterial genome in four hours. Solexa announced that it would begin shipping its 1G Analyzer instrument – capable of sequencing 1 billion bases of DNA per instrument per day – by early next year.

Back in 2003, Venter’s science foundation established a $500,000 technology prize to stimulate developments in automated DNA sequencing technology that would bring about the sequencing of a human genome for about $1,000. “Once this threshold has been reached, it will be feasible for the majority of individuals to have their genome sequenced and encoded as part of their medical record,” Venter stated through his foundation in 2003.

At the conference, Tony Smith, vice president of Solexa, and 454 founder Jonathan Rothberg both said that they expected to reach the $100,000 genome plateau next year. Impressive as these milestones are, Venter clearly wants even faster progress. “I [previously] described the genome community when talking about cost as the Liar’s Club,” said Venter. “[We’re] trying to [raise] the prize by 10- to 20-fold. But we’re going to be putting some real limits on things.”

Noting that Solexa believes it can deliver a $10,000 genome by 2008, Venter said, “Our goal is really to have a $1,000 genome, but instead of having accountants tell us what it is, we’re going to require people to sequence maybe 100 genomes and really demonstrate the technology. So we’re trying to finalize the rules for this.”

“We’re thinking of a timeline that this has to be done sometime between 2008 and 2010. We’re trying to raise the prize value to reward the scientists that actually come up with these breakthroughs, not by calculation but by actual demonstration.”

Venter said he was in discussions with the X Prize Foundation, of which he is on the Board of Trustees, to find means of increasing the size of the award.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

checkmark
Bio-IT World Clinical Trials Survey Results
Sponsored by CHI

This brief survey is intend to provide insight into three areas:

  • Key clinical process challenges facing the industry
  • Trends in cloud computing usage and projects growth within the clinical sector
  • Usage of outsources services and projected growth


hp_4_4
Accelerating Decision Making Processes in Life Sciences R&D
Sponsored by HP and Microsoft

Life sciences organizations need an easy way to access and share information to make timely R&D decisions. Read this white paper to learn:

  • How IT and business challenges complicate decision-making efforts
  • How to avoid missed opportunities, duplicate work, and inefficient use of time
  • How a jointly developed HP and Microsoft business intelligence appliance provides a way for life sciences researchers and managers to accelerate their analysis and decision-making work.


pegasystems_5_13
A BPM-Approach to Adverse Event Management
Sponsored by Pegasystems

Safety management is one of the most difficult requirements imposed on the life sciences industry. Companies confront a tangle of safety monitoring requirements that span both pre- and post-market approval activities and vary by IRB/IEC governance policies, product type, and different global regulatory agencies. Learn how Pegasystems BPM and its Adverse Event Case Processing Solution (AECP) can help companies

  • Transform adverse event management systems
  • Lower cost with increased productivity
     

One client successfully utilized Pega BPM to establish paperless adverse event reporting across 23 countries, resulting in upwards of a 100% increase in productivity with near 50% cost reduction.
 



Job Openings

  astra revised logo 11152011 

AstraZenca - Biomedical Informatics Director - Competitive + excellent benefits - Wilmington (US), Alderley Park (UK), Mölndal (Sweden)

As a Biomedical Informatics Director – Real World Evidence at AstraZeneca, you’ll have all the resources and support you need to make your mark. Join us, and you’ll develop a strategic plan for utilising relevant healthcare data, advanced analytical methodologies and knowledge management solutions that will support evidence-based decisions. Click for more information

 

AstraZenca - Biomedical Informatician – Real World Evidence - Wilmington (US), Alderley Park (UK), Mölndal (Sweden)

You'll advise on the best computational approaches to deliver sound, evidence-based decisions and innovative processes, tools and approaches to manage drug project information.   You’ll have extensive experience of bioscience, medicine or another clinical field, with training in computer science or informatics, and experience in the pharmaceutical industry.  You’ll promote the most effective use of informatics solutions, coordinate the contribution of informatics scientists and lead cross-functional delivery teams.  Click for more information  

 

 harvard 

Harvard Medical School - Chief Information Officer - Boston, MA 

Harvard Medical School seeks a new Chief Information Officer to lead its IT organization and develop solutions within a cutting-edge research and educational environment. Successful candidates will have 10 to 15 years of directly related professional experience, including 10 years supervisory with increasing responsibility.  Demonstrated leadership with ability to create and execute IT vision and strategy for a complex academic organization are essential. For further information or to apply, please contact:

Julie Stanley/Harvard Medical School
Department of Human Resources/Gordon Hall, 312
25 Shattuck Street
Boston, MA 02115
Phone #617-432-3273  Julie_Stanley@hms.harvard.edu
To apply please go to:  http://www.employment.harvard.edu/
 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .